Therefore, to answer these questions we (1) examined the effect of P2 receptor activation on the outflow of [ 3 H]noradrenaline from rat hippocampal slices, (2) explored the mRNA expression of different P2 receptor subtypes in the brainstem containing catecholaminergic nuclei projecting to the hippocampus, and based on these data (3) an attempt was made to identify the underlying receptor subunits.
Methods
All studies were conducted in accordance with the principles and procedures outlined in the NIH Guide for the Care and use of Laboratory animals and were approved by the local Animal Care Committee of the Institute of Experimental Medicine (Budapest, Hungary).
Experiments on [ 3 H]noradrenaline outflow from rat hippocampal slices
Tritium outflow experiments were carried out by the application of the method described in our earlier papers (e.g. Sperlágh et al., 2000) to rat hippocampal slices. Briefly, male
Wistar rats (140-160 g, Charles-River Ltd, Budapest, Hungary) were anaesthetized under light CO 2 inhalation, and then decapitated. The hippocampi were dissected in icecold Krebs' solution saturated with 95% O 2 and 5% CO 2 , and 400 µm-thick slices were prepared by a McIlwain tissue chopper and incubated in 1 ml of modified Krebs solution (mM: NaCl 113, KCl 4.7, CaCl 2 2.5, KH 2 PO 4 1.2, MgSO 4 1.2, NaHCO 3 25.0, glucose 11.5, pH 7.4) containing 370 kBq/ml [ 3 H]NA (0.27 µM, specific activity 1.36 TBq/mmol; Amersham), ascorbic acid (30 µM) and Na 2 EDTA (100 µM) for 60 min. The medium was bubbled continuously with 95% O 2 and 5% CO 2 and maintained at 37 o C. After loading, the slices were rinsed three times with 6 ml Krebs' solution, transferred to polypropylene tissue chambers, and superfused continuously with 95% O 2 -and 5% CO 2 -saturated modified Krebs' solution (37 o C, flow rate: 0.7 ml/min) containing ascorbic acid (30 µM), and Na 2 EDTA (100 µM) for 60 min. Subsequently, perfusate samples were collected over a 3-min period and assayed for tritium. Preparations were subjected to two identical periods of electrical field stimulation (EFS 1 , EFS 2 , 25V, 1 msec, 2 Hz, 240 shocks) delivered by a Grass S88 stimulator (Grass Medical Instruments, Quincy, MA, USA) or to two 6-min perfusion of agonists (ATP, ADP, α,β-methyleneATP) with 30 min interval, in the absence or presence of drugs (PPADS, Brilliant blue G, NF023, NF449, MRS2179, DPCPX, DMPX, TTX, AP-5, CNQX, desipramine), which were preperfused 18 min before the second agonist application. Concentration response curve to P2
agonists were obtained upon tritium release elicited by S 1 . Since it is known that the high concentrations of ATP used in this study significantly acidify the dissolving medium (Sperlágh et al., 2002) , the pH of the ATP-containing perfusing solution was routinely adjusted to pH 7.4, except when the effect of the low pH was tested: in these experiments the pH of the ATP containing buffer was adjusted to pH 6.5. Likewise, a millimolar concentration of ATP alters the Ca 2+ concentration of the medium, which -by changing the excitability of the membranes -might elicit transmitter release by itself.
Nevertheless, this was not the case in our experiments, because restoring the Ca 2+ concentration to 2.5 mM did not significantly alter ATP-evoked tritium outflow (data not shown). In some experiments the slices were preincubated with the G i protein inhibitor pertussis toxin (2.5 µg/ml) for 12 h before and during the loading period, and for respective controls, an identical period of preincubation was performed with drug-free Krebs' solution. In other experiments Ca 2+ -free Krebs' solution or Na + -free Krebs' solution supplemented with equimolar choline chloride was perfused for 60 min during the whole preperfusion period and thereafter in order to obtain complete replacement of unbound Ca 2+ or sodium.
The radioactivity released from the preparations was measured with a Packard 1900
Tricarb liquid scintillation spectrometer (Packard, Canberra, Australia) which is equipped with Dynamic Color Corrected DPM Option providing absolute activity (DPM) calculation and correction for all kinds of color quenching. A 0.5-ml aliquot of the perfusate sample was added to 4 ml of liquid scintillation fluid (Packard ULTIMA GOLD) and counts were determined. For determining the residual radioactivity, the tissues were weighed and homogenized, and the radioactivity was extracted with 10% trichloroacetic acid. The counts were converted to absolute activity by the external standard method. Outflow of tritium was expressed in Bq/g and as a percentage of the amount of radioactivity in the tissue at the sample collection time (fractional release). When the effect of different treatments and drugs on basal outflow were evaluated the fractional release measured in a 3-min sample collected immediately before the second ATP perfusion (the 12th sample) were taken into account in the absence and presence of drugs, respectively.
Agonist-induced tritium outflow (S 1 , S 2 ) was expressed by calculating the net release in response to agonist application by the area-under-the-curve method, i.e., by subtracting the release before the agonist application from the values measured after agonist application and a similar method was applied to calculate electrical field stimulationevoked tritium outflow (EFS 1 , EFS 2 ). The effect of drugs on the agonist-evoked outflow of tritium was expressed as S 2 /S 1 ratios measured in the absence and presence of the drug, respectively.
HPLC analysis
The composition of the tritium label in the hippocampal superfusate fluid was determined by a Gilson HPLC system using on-line enrichment with electrochemical and liquid scintillation detection, as described earlier (Sántha et al., 2000) . p2y receptor cDNAs and β-actin primers for control amplification were identical to that used in our previous study (Sperlagh et al., 2003) , the GenBank Accession Numbers were the following: p2x1:NM_012997, p2x2:U14414, p2x3:NM_031075, p2x4:X91200, p2x5:X92069, p2x6:X97376, p2x7:NM_019256, p2y1:U22830, p2y2:NM_017255, p2y4:NM_031680, p2y6:D63665, ß-actin:X03765. The conditions for amplification were as follows: initial denaturation at 95 ºC, 5', hot start at 80 ºC, then 94 ºC, 1', 59 ºC, 1' and 72 ºC, 1' for 40 cycles, with a final extension at 72 ºC, 5'. PCR products were analyzed by agarose gel electrophoresis. The identity of the amplified PCR products with the expected size has previously been verified by sequencing (Sperlagh et al., 2003) .
Genomic DNA contamination in RNA samples was ruled out by direct PCR amplification of RNA samples. 
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Statistics
All data were expressed as means±s.e.mean of n observations. The statistical analyses were made by one way analysis of variance (ANOVA) followed by Dunnett or Tukey post hoc test (multiple comparisons), or Student's t-test (pairwise comparisons). P values of less than 0.05 were considered statistically significant.
Results
The overall radioactivity uptake of the slices was 7.32±0.35 x10 5 Bq/g (n=12 (Table 1) . Besides ATP, other ATP analogues, known to act as agonists on P2 receptors were also effective in eliciting concentration-dependent and amplified by PCR using primers specific to different P2X and P2Y receptor subtypes. RT-PCR analysis showed that the sizes of the P2X 1 , P2X 2 , P2X 3 , P2X 4 , P2X 6 , P2X 7 and P2Y 1 specific amplification products were consistent with the expected sequence-based product sizes, indicating the expression of these P2 receptor subtypes in the rat brainstem ( Figure 3 ). Their veracity was confirmed in previous studies by sequencing of the amplified PCR products (Sperlagh et al., 2003) . When PCR was performed on RNA samples without reverse transcription, there were no products, indicating that the template for amplification was the mRNA rather then the contaminating genomic DNA (data not shown). Amplification of β -actin was used as an internal control. Among P2X receptor subunits, mRNA encoding the P2X 5 subunit was below the detection limit, whereas among P2Y receptors we couldn't detect the expression of P2Y 2, P2Y 4 and P2Y 6 receptors ( Figure 3 ). In our previous study (Sperlágh et al., 2003) , using the same primer sets, mRNAs encoding all these subtypes were expressed in the rat hippocampus, which can be regarded as a positive control for the present experiments. mRNA expression of P2Y 11 , P2Y 12 P2Y 13 and P2Y 14 receptors was not examined in the present study.
Next, the effect of ATP on [ 3 H]NA outflow was tested in the presence of a variety of P2 receptor antagonists ( (Table 2) . To further delineate the P2X receptor subunits involved in the action of ATP the effect of the change of extracellular pH was examined. It is known that ionotropic P2X receptors display differential sensitivity to the change of pH: the majority of the receptors, such as P2X 1 and P2X 3 , decrease their activity at lower pH, while others, such as P2X 2 and P2X 2/3 , increases their activity under these conditions (North, 2002) . In our experiments, reduction of the pH of the Krebs' solution from 7.4 to 6.5 decreased the response by ATP (10 mM) to less than half (1.29±0.03% and 0.54±0.11% at pH 7.4 and 6.5 respectively, n=4, P<0.01).
Since mRNA encoding P2Y 1 receptors was also expressed in the brainstem (see Figure   3 ), one might assume that it could be also responsible for the effect of ATP analogues.
Nevertheless, the P2Y 1 receptor selective antagonist MRS 2179 (10 µM) (Boyer et al., 1998) Figure 4B ).
Discussion
In this study we explored the facilitatory effect of P2 receptor activation on the outflow of Although this concentration is higher than its affinity to P2X 1 receptor but is still below the concentration necessary to inhibit the P2X 3 or P2X 2/3 receptor. Therefore, the involvement of P2X 1 receptors or other unidentified heteromeric coassemblies P2X receptor subunits in this effect cannot be entirely excluded.
Since it is known that lowering the pH differentially affects the response mediated by them, the effect of a change in the extracellular pH was tested. Lowering the extracellular pH from 7.4 to 6.5 significantly inhibited ATP-evoked [ 3 H]NA outflow, which is in agreement with the involvement of P2X 1 and P2X 3 receptors, but argues against the involvement of the P2X 2/3 receptor, which responds to the acidic environment with potentiation. For the same reason, a role for the newly identified P2X 1/2 combinations, also seems unlikely (Brown et al., 2002) .
Besides P2X receptors, ATP evoked [ 3 H]NA outflow could also be mediated by other nucleotide-sensitive receptors, i.e. the P2Y subfamily, and among them mRNA encoding the P2Y 1 receptor, but not P2Y 2 , P2Y 4 , and P2Y 6 , was present in the brainstem.
However, MRS2179, a selective antagonist of P2Y 1 receptors (Boyer et al., 1998) , did not significantly affect the action of ATP. Although we have not explored the mRNA expression of the four newly identified P2Y receptor subtypes, i.e., P2Y 11 , P2Y 12 , P2Y 13 , P2Y 14 , our pharmacological findings do not support their involvement in the action of ATP for the following reasons: (1) although α,β−methyleneATP is also an agonist of the P2Y 11 receptor, this receptor is insensitive to PPADS, which acted as an antagonist in our experiments, (2) According to the present knowledge P2Y 12 and P2Y 13 are coupled to G i proteins, but inhibition of G i proteins with pertussis toxin did not affect ATP evoked We also identified the underlying mechanism responsible for the effect of ATP in our experiments. Being unaffected by TTX, action potential propagation seems to play a minor role in this effect. On the other hand, the activation of glutamate receptors elicits noradrenaline release from the hippocampus (Pittaluga and Raiteri, 1992), therefore we explored the role of endogenous glutamate release and subsequent glutamate receptor activation in this effect. When NMDA and non-NMDA receptors were completely inhibited by a cocktail of AP-5 and CNQX, a small, but significant attenuation of the effect of ATP was observed, showing that local or non-synaptic glutamate receptor activation might be partly involved in this response. Omission of Na + , but not Ca 2+ from the perfusion medium abolished ATP-evoked [ 3 H]NA outflow, which implies that the mechanism responsible for the action of ATP is a direct influx of sodium through the receptor ion channel complex. Although P2X receptor-gated ion channels are also to facilitate noradrenaline release; however, the differentiating effect of the low pH was not tested in that study (Queiroz et al., 2003) . Taken into account that glutamatergic excitatory terminals are equipped with presynaptic P2X 2 and P2X 7 receptors (Khakh et al., 2003; Sperlagh et al., 2002) , glutamatergic and noradrenergic transmission in the hippocampus could be distinctly regulated by facilitatory P2X receptors. Total RNA samples from the brainstem were reverse transcribed and amplified by PCR using primers specific to P2X and P2Y receptor transcripts. Amplification of β -actin was used as an internal control. The lengths of P2X 1 , P2X 2 , P2X 3 , P2X 4 , P2X 6 , P2X 7 , P2Y 1 specific PCR products were as expected, indicating the expression of these P2
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receptor subtypes in the rat brainstem. The identity of the amplified PCR products has previously been verified by sequencing (Sperlagh et al., 2003) . A 100-bp DNA ladder (Fermantas, Vilnius, Lithuania) was used to identify PCR fragment sizes. The gel shown is representative of at least three independent experiments. Experiments were performed according to the protocol shown on Figure 1 . The samples collected immediately before and after ATP (10 mM) perfusion were analyzed by HPLC-EC technique. Results are expressed as a percentage of the total radioactivity released (%). Data show the mean±s.e.mean of 8 observations. Experiments were performed according to the protocol shown on Figure 1 . Results are expressed as S 2 /S 1 ratios measured in the absence of presence of drugs. P2
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antagonists were preperfused 18 min before the second ATP stimulus (S 2 ). Data show the mean±s.e.mean of n observations. n= number of experiments. P values indicate significant differences from control, calculated by ANOVA followed by the Dunnett test. 
